Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis
Clicks: 132
ID: 269556
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.6
/100
12 views
12 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In the present meta-analysis, levosimendan infusion in patients with ADHF appeared to reduce BNP regardless of the comparator (except for dopamine), and also improve LVEF and increase HR in after vs. before use comparisons but not compared to controls. Future larger studies on the benefit of levosim …
| Reference Key |
s2019herzeffect
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhou S;Zhang L;Li J;; |
| Journal | herz |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Prospective Studies
l zhang
pmid:29637229
doi:10.1007/s00059-018-4693-3
s zhou
j li
cardiotonic agents* / therapeutic use
heart failure* / drug therapy
hydrazones
pyridazines*
simendan* / therapeutic use
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.